ClinicalTrials.govpublic full text
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
obesity and overweight, obese adolescents, weight management, weight loss, cardiovascular disease risk factor, semaglutide, wegovy, ozempic, obesity, overweight, adolescent, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 901850
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.